UPDATE 3-Express Scripts says costly new cholesterol drugs could 'wreak havoc'

July 29 (Reuters) - Express Scripts Holding Co, the largest pharmacy benefit manager in the United States, on Wednesday said the cost of potent, newly approved cholesterol drugs could "wreak financial havoc" among its clients.